AGTX-2003

N/A

Report date: 2025/06/11 11:14:36
NME

Base Information

Drug NameAGTX-2003
Drug Alias Namecannabinoid CB1 receptor inverse agonist (Agentix)AGTX-2003RTI-1092769ABP-2003
ClassificationSmall molecules
Mechanisms of ActionCannabinoid CB1 receptor inverse agonists
TargetsCannabinoid CB1 receptor
Therapy Area/IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRti International
China Registration ClassN/A

Develop Information

Active CompaniesAgentix Corp
Inactive CompaniesRti International
Active IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A